Maze Therapeutics, Inc. (MAZE)

44.22 -0.82 (-1.82%) USD  |  NASDAQ  |  Feb 20, 16:00
45.00 +0.78 (+1.76%) After-Hours: 20:00
More

Maze Therapeutics Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for MAZE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
CDT Equity, Inc. Upgrade
LENZ Therapeutics, Inc. Upgrade
Liminatus Pharma, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. Upgrade